Literature DB >> 29674524

Insulin Receptor Plasma Membrane Levels Increased by the Progesterone Receptor Membrane Component 1.

Kaia K Hampton1, Katie Anderson1, Hilaree Frazier1, Olivier Thibault1, Rolf J Craven2.   

Abstract

The insulin receptor (IR) is a ligand-activated receptor tyrosine kinase that has a key role in metabolism, cellular survival, and proliferation. Progesterone receptor membrane component 1 (PGRMC1) promotes cellular signaling via receptor trafficking and is essential for some elements of tumor growth and metastasis. In the present study, we demonstrate that PGRMC1 coprecipitates with IR. Furthermore, we show that PGRMC1 increases plasma membrane IR levels in multiple cell lines and decreases insulin binding at the cell surface. The findings have therapeutic applications because a small-molecule PGRMC1 ligand, AG205, also decreases plasma membrane IR levels. However, PGRMC1 knockdown via short hairpin RNA expression and AG205 treatment potentiated insulin-mediated phosphorylation of the IR signaling mediator AKT. Finally, PGRMC1 also increased plasma membrane levels of two key glucose transporters, GLUT-4 and GLUT-1. Our data support a role for PGRMC1 maintaining plasma membrane pools of the receptor, modulating IR signaling and function.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29674524      PMCID: PMC5987996          DOI: 10.1124/mol.117.110510

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  57 in total

1.  Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expression.

Authors:  Laura Sciacca; Maria Francesca Cassarino; Marco Genua; Paolo Vigneri; Maria Giovanna Pennisi; Pasqualino Malandrino; Sebastiano Squatrito; Vincenzo Pezzino; Riccardo Vigneri
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

2.  Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.

Authors:  F Frasca; G Pandini; P Scalia; L Sciacca; R Mineo; A Costantino; I D Goldfine; A Belfiore; R Vigneri
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors.

Authors:  Gerard Crudden; Ralf Loesel; Rolf J Craven
Journal:  Tumour Biol       Date:  2005-06-20

4.  Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1.

Authors:  Shakeel U R Mir; Ling Jin; Rolf J Craven
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

5.  A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes.

Authors:  Farah Alghamdi; Merry Guo; Samar Abdulkhalek; Nicola Crawford; Schammim Ray Amith; Myron R Szewczuk
Journal:  Cell Signal       Date:  2014-02-28       Impact factor: 4.315

6.  Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule.

Authors:  Ikhlas S Ahmed; Hannah J Rohe; Katherine E Twist; Marlene N Mattingly; Rolf J Craven
Journal:  J Pharmacol Exp Ther       Date:  2010-02-17       Impact factor: 4.030

7.  Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor.

Authors:  Emma E Vincent; Douglas J E Elder; Jon Curwen; Elaine Kilgour; Ingeborg Hers; Jeremy M Tavaré
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

8.  Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site.

Authors:  Jinbin Xu; Chenbo Zeng; Wenhua Chu; Fenghui Pan; Justin M Rothfuss; Fanjie Zhang; Zhude Tu; Dong Zhou; Dexing Zeng; Suwanna Vangveravong; Fabian Johnston; Dirk Spitzer; Katherine C Chang; Richard S Hotchkiss; William G Hawkins; Kenneth T Wheeler; Robert H Mach
Journal:  Nat Commun       Date:  2011-07-05       Impact factor: 14.919

Review 9.  Ligand-mediated endocytosis and trafficking of the insulin-like growth factor receptor I and insulin receptor modulate receptor function.

Authors:  Alaide Morcavallo; Manuela Stefanello; Renato V Iozzo; Antonino Belfiore; Andrea Morrione
Journal:  Front Endocrinol (Lausanne)       Date:  2014-12-17       Impact factor: 5.555

10.  Pathways driving the endocytosis of mutant and wild-type EGFR in cancer.

Authors:  Kaia K Hampton; Rolf J Craven
Journal:  Oncoscience       Date:  2014-07-29
View more
  13 in total

1.  Glycogen metabolism in mink uterine epithelial cells and its regulation by estradiol, progesterone and insulin.

Authors:  Ayokunle Hodonu; Mario Escobar; Logan Beach; Jason Hunt; Jack Rose
Journal:  Theriogenology       Date:  2019-02-27       Impact factor: 2.740

Review 2.  Pleiotropic Actions of PGRMC Proteins in Cancer.

Authors:  James K Pru
Journal:  Endocrinology       Date:  2022-07-01       Impact factor: 5.051

3.  The impact of acute rosiglitazone on insulin pharmacokinetics at the blood-brain barrier.

Authors:  Demi C Galindo; William A Banks; Elizabeth M Rhea
Journal:  Endocrinol Diabetes Metab       Date:  2020-06-04

4.  Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived α-synuclein.

Authors:  Colleen S Limegrover; Raymond Yurko; Nicholas J Izzo; Kelsie M LaBarbera; Courtney Rehak; Gary Look; Gilbert Rishton; Hank Safferstein; Susan M Catalano
Journal:  J Neurosci Res       Date:  2021-01-22       Impact factor: 4.164

5.  Pgrmc1 Knockout Impairs Oocyte Maturation in Zebrafish.

Authors:  Xin-Jun Wu; Peter Thomas; Yong Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-24       Impact factor: 5.555

6.  Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation.

Authors:  Aviva Rabin-Court; Marcos R Rodrigues; Xian-Man Zhang; Rachel J Perry
Journal:  PLoS One       Date:  2019-06-12       Impact factor: 3.240

7.  Epitope mapping of anti-PGRMC1 antibodies reveals the non-conventional membrane topology of PGRMC1 on the cell surface.

Authors:  Ji Yea Kim; So Young Kim; Hong Seo Choi; Sungkwan An; Chun Jeih Ryu
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

8.  Progesterone receptor membrane associated component 1 enhances obesity progression in mice by facilitating lipid accumulation in adipocytes.

Authors:  Ryogo Furuhata; Yasuaki Kabe; Ayaka Kanai; Yuki Sugiura; Hitoshi Tsugawa; Eiji Sugiyama; Miwa Hirai; Takehiro Yamamoto; Ikko Koike; Noritada Yoshikawa; Hirotoshi Tanaka; Masahiro Koseki; Jun Nakae; Morio Matsumoto; Masaya Nakamura; Makoto Suematsu
Journal:  Commun Biol       Date:  2020-09-04

9.  Clozapine Induced Disturbances in Hepatic Glucose Metabolism: The Potential Role of PGRMC1 Signaling.

Authors:  Ting Cao; Qian Chen; BiKui Zhang; XiangXin Wu; CuiRong Zeng; ShuangYang Zhang; HuaLin Cai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-14       Impact factor: 5.555

10.  Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex.

Authors:  Aladdin Riad; Chenbo Zeng; Chi-Chang Weng; Harrison Winters; Kuiying Xu; Mehran Makvandi; Tyler Metz; Sean Carlin; Robert H Mach
Journal:  Sci Rep       Date:  2018-11-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.